Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Antimicrobial Agents and Chemotherapy|November 21, 2007
Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infectionJennifer J Kiser, Courtney V Fletcher, Patricia M Flynn, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2017
Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed TherapyPeter L Anderson, Albert Y Liu, Jose R Castillo-Mancilla, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 21, 2019
Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected IndividualsSusanna Naggie, Daniel S Fierer, Michael D Hughes, et al.
The Journal of Antimicrobial Chemotherapy|May 17, 2019
Pharmacokinetics of tenofovir monoester and association with intracellular tenofovir diphosphate following single-dose tenofovir disoproxil fumarateKristina M Brooks, Mustafa E Ibrahim, Jose R Castillo-Mancilla, et al.
Clinical Pharmacology and Therapeutics|September 15, 2020
Optimizing Pharmacology Studies in Pregnant and Lactating Women Using Lessons From HIV: A Consensus StatementAhizechukwu C Eke, Adeniyi Olagunju, Jeremiah Momper, et al.
The Journal of Antimicrobial Chemotherapy|February 23, 2022
Predictors of 007 triphosphate concentrations in dried blood spots in persons with hepatitis C and active drug or alcohol useKristina M Brooks, Jose R Castillo-Mancilla, Mary Morrow, et al.
JAMA Pediatrics|September 6, 2017
Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United StatesSybil G Hosek, Raphael J Landovitz, Bill Kapogiannis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2024
Sofosbuvir/Velpatasvir Pharmacokinetics, Safety, and Efficacy in Pregnant People With Hepatitis C VirusCatherine A Chappell, Jennifer J Kiser, Kristina M Brooks, et al.
The Journal of Antimicrobial Chemotherapy|May 11, 2018
Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarateChristine E MacBrayne, Kristen M Marks, Daniel S Fierer, et al.
The Journal of Antimicrobial Chemotherapy|August 9, 2020
Pharmacokinetics and renal safety of tenofovir alafenamide with boosted protease inhibitors and ledipasvir/sofosbuvirKristina M Brooks, Jose R Castillo-Mancilla, Mary Morrow, et al.
Pageof 10